ConsumerDaily Briefs

Daily Brief Consumer: Denso Corp, Toyota Motor, L’Occitane, Dekon Food and Agriculture Group, Perfect Medical Health, Mitsubishi Motors, Meituan and more

In today’s briefing:

  • Huge Denso (6902) Secondary Sale by Toyota Group – Admiral Ackbar Says “It’s A Trap!”
  • Denso Offering, Buyback, and New Cross-Holding Reduction Policy – It WAS a Trap
  • StubWorld: Toyota Group To Sell 10% of Denso; Adelson Selling LVS
  • Denso (6902 JP): US$4.0 Billion Secondary Offering and US$1.4 Billion Buyback
  • Denso Corp Placement – Toyota to Raise US$4.4bn, as Expected
  • L’Occitane (973 HK):  FY1H24 Earnings Hurt By Massive Increase In Marketing, As Expected
  • Dekon Food and Agriculture Group IPO – Ebbs and Flows of Cycle Have Hurt Profitability
  • Perfect Medical H1 FY24: Rebound of Growth in H2 FY24, 9% Div Yield, New High ROIC Investment
  • Quiddity JPX-Nikkei 400 Rebal 2024: End-Nov 2023
  • Meituan: Earnings to Weaken Further


Huge Denso (6902) Secondary Sale by Toyota Group – Admiral Ackbar Says “It’s A Trap!”

By Travis Lundy

  • Yesterday, Reuters reported that multiple Toyota Group companies would sell ~10% of Denso Corp (6902 JP) worth ¥700bn in a secondary share sale by year-end.
  • The sellers would be Toyota, selling down to just over 20%, Toyota Industries (6201) (selling down a bit more than half, and Aisin Seiki (7259 JP) selling its 2% stake. 
  • Denso would buy back shares. This whole thing is both interesting and complicated so I discuss the interesting complications below. It looks bigger than it probably is.

Denso Offering, Buyback, and New Cross-Holding Reduction Policy – It WAS a Trap

By Travis Lundy

  • 15 minutes after I published what I thought was a considered analysis, Denso dumps the details. I thought it might be a trap. It looks like a trap.
  • A holistic view of the three different documents here suggests, indeed, “It was a trap”. 
  • This giant offering is not bearish overhang but likely tilts bullish with greenshoe support, a large buyback, a new cross-holding reduction policy, and the follow-on effects from that.

StubWorld: Toyota Group To Sell 10% of Denso; Adelson Selling LVS

By David Blennerhassett


Denso (6902 JP): US$4.0 Billion Secondary Offering and US$1.4 Billion Buyback

By Arun George

  • Denso Corp (6902 JP) announced a secondary offering of up to 294.8 billion shares (including overallotment) and a buyback (maximum shares of 125 million or maximum value of JPY200 billion).
  • Denso also announced a cross-holding reduction policy. In an unspecified timeframe, it will sell part of its holdings in Toyota Industries (6201 JP) and Aisin (7259 JP).
  • Looking at recent large Japanese placements is instructive to understand the potential offer price. The pricing date will fall between 13 and 18 December (likely 13 December).

Denso Corp Placement – Toyota to Raise US$4.4bn, as Expected

By Sumeet Singh


L’Occitane (973 HK):  FY1H24 Earnings Hurt By Massive Increase In Marketing, As Expected

By Steve Zhou, CFA

  • L’Occitane (973 HK) reported FY1H24 (fiscal year ending March 31) results yesterday after market, with net profit down 45% yoy. 
  • The sharp drop in earnings is mainly due to a 48% yoy increase in marketing costs, as well as increased finance costs.
  • The company maintained the FY24 outlook of 17% topline growth and an operating profit margin of 12% (FY1H24:  7.2%). 

Dekon Food and Agriculture Group IPO – Ebbs and Flows of Cycle Have Hurt Profitability

By Clarence Chu

  • Dekon Food and Agriculture Group (DFAG CH) is looking to raise up to US$128m in its Hong Kong IPO.
  • Dekon Food and Agriculture Group (DFAG) is a vertically integrated livestock farming enterprise in China.
  • In this note, we will look at past performance, and share our thoughts on valuation.

Perfect Medical H1 FY24: Rebound of Growth in H2 FY24, 9% Div Yield, New High ROIC Investment

By Sameer Taneja

  • Perfect Medical Health (1830 HK) results showed 7% revenue growth and 10% YoY profit (27% YoY adjusted profit for subsidies) growth in H1 FY24.
  • The company declared a 14.2 cent/share interim dividend. H2 dividends usually are higher, so we expect a 32-35 cent dividend for FY24. 
  • This is another dividend-yielding gem, trading at 12.0x PE FY24e, a 9% dividend yield, and 15% of the market cap in cash and investments with a >50% ROE. 

Quiddity JPX-Nikkei 400 Rebal 2024: End-Nov 2023

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted market-value-weighted (capped) index composed of 400 constituents.
  • A periodic review is conducted by the Index providers, the JPX Group and Nikkei Inc, in August every year. We look at the rankings of the potential ADDs/DELs every month.
  • Below is a look at potential ADDs/DELs for the JPX-Nikkei 400 Index Rebal to come in August 2024 based on trading data as of end-November 2023.

Meituan: Earnings to Weaken Further

By Shifara Samsudeen, ACMA, CGMA

  • Meituan (3690 HK) ‘s 3Q2023 revenues beat estimates while OP for the quarter was well below consensus estimates.
  • There were clear signs of slowdown in earnings growth due to macroeconomic challenges and weaker demand. 4Q earnings are expected to decline further.
  • Meituan’s share price went down by about 11% following its earnings announcement as slowdown in core local commerce and weakening earnings have concerned investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars